Penn researchers gain new insights on spinal muscular atrophy
Researchers from the University of Pennsylvania School of Medicine discovered that the effect of a protein deficiency, which is the basis of the neuromuscular disease spinal muscular atrophy (SMA), is not restricted to motor nerve cells, suggesting that SMA is a more general disorder. This new insight will allow for better understanding of how this complex disease arises. Gideon Dreyfuss, PhD, the Isaac Norris Professor of Biochemistry and Biophysics and Investigator, Howard Hughes Medical Institute and colleagues, report their findings in last week's issue of Cell. SMA is a group of hereditary diseases that causes weakness and wasting of the voluntary muscles in the arms and legs of infants and children. The disorders are a result of genetic lesions in a gene called survival of motor proteins (SMN) that cause a deficiency in the SMN protein. This protein is essential for all cells, but reduced levels of SMN cause spinal muscular atrophy. Why this seemingly cell-specific reduction happens is not known.
SMN normally works in all cells to bring small RNAs together with specific proteins to form particles called snRNPs (pronounced snurps). snRNPs are the molecular machines that splice different parts of RNA together to form the messenger RNA (mRNA) before it leaves the nucleus to travel to the cytoplasm. Here, mRNAs get translated into working proteins.
"SMN plays a key role in determining the inventory of the different types of snRNPs in all cells, what we call the snRNP repertoire or the 'snRNPertoire,'" says Dreyfuss. "When SMN levels are reduced, the biochemical balance needed to make the snRNP complexes for splicing RNA is impaired."
The Dreyfuss lab looked at reduced SMN levels in cultured cells and mice and found that changes in levels of the snRNPs, as well as the mRNAs – their spliced products – were affected, producing numerous abnormal mRNAs. These effects varied from tissue to tissue. The findings suggest that spinal muscular atrophy is a general disease of splicing.
"Now we know that SMA is clearly a disease that not only affects motor neurons, but all cell types when the gene for SMN is damaged," says Dreyfuss. In the end, concludes Dreyfuss, this is a different way to look at the disease. Finding a way to restore SMN levels in the entire body is one therapeutic approach to aim for, based on these findings.
- Antisense therapy delivers long-term correction of severe spinal muscular atrophy in miceWed, 5 Oct 2011, 23:38:10 EDT
- Rare window on spinal muscular atrophy geneticsTue, 7 Apr 2009, 6:14:56 EDT
- Researchers identify drug candidate for treating spinal muscular atrophyWed, 4 Nov 2009, 15:44:09 EST
- ISU researchers find possible treatment for spinal muscular atrophyMon, 27 Jul 2009, 14:37:03 EDT
- New therapy offers hope to spinal muscular atrophy patientsWed, 9 Jun 2010, 14:53:45 EDT
- Scientists gain new insights on spinal muscular atrophyfrom Science CentricFri, 30 May 2008, 17:07:10 EDT
- Researchers gain new insights on spinal muscular atrophyfrom PhysorgThu, 29 May 2008, 15:14:08 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- How mosquitoes are drawn to human skin and breath
- Fledgling supernova remnant reveals neutron star's secrets
- New fossil species found in Mozambique reveals new data on ancient mammal relatives
- Multi-dog study points to canine brain's reward center
- Geoengineering approaches to reduce climate change unlikely to succeed
- Stanford study suggests why, in some species, mere presence of males shortens females' lifespan
- 'Spooky action' builds a wormhole between 'entangled' quantum particles
- The mystery of neutron stars heats up
- New report calls for attention to abrupt impacts from climate change
- Mysteries of Earth's radiation belts uncovered by NASA twin spacecraft